CE: MAbs and issues in biotechnology

IQVIA’s Doug Long offers a lay of the land, including trends and developing issues that are shaping the current market.

LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.

The German company will expand its access into the United States through the acquisition.

Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.

The famous trees, and the festival associated with their blossoming each spring, is part of a tradition for the global pharmaceutical company.

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug development landscape.